You have 9 free searches left this month | for more free features.

NeupogenTM

Showing 1 - 8 of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Angiosarcoma Trial in Houston (Paclitaxel, mRNA plus Lysate-loaded Dendritic Cell Vaccine, PEGYLATED-INTERFERON ALPHA-2A)

Not yet recruiting
  • Angiosarcoma
  • Houston, Texas
    M D Anderson Cancer Center
Mar 23, 2023

Myeloma Trial in Houston (drug, other, procedure)

Completed
  • Myeloma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 7, 2020

Recurrent Implantation Failure, Endometriosis Trial (Granulocyte Colony-Stimulating Factor, Intrauterine infusion of normal

Unknown status
  • Recurrent Implantation Failure
  • Endometriosis
  • Granulocyte Colony-Stimulating Factor
  • Intrauterine infusion of normal saline
  • (no location specified)
May 26, 2018

Leukemia, Lymphoma, Myeloma Trial in Houston (Fludarabine, Melphalan, Alemtuzumab)

Terminated
  • Leukemia
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 18, 2016

Lymphoma Trial in Houston (Vorinostat, Gemcitabine, Busulfan)

Completed
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 17, 2015

Myelodysplastic Syndrome, Aplastic Anemia Trial in Houston (Thymoglobulin, Cyclosporine, Methylprednisolone)

Completed
  • Myelodysplastic Syndrome
  • Aplastic Anemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Mar 8, 2013

Multiple Myeloma Trial in Houston (Pegfilgrastim (Neulasta), Apheresis)

Completed
  • Multiple Myeloma
  • Pegfilgrastim (Neulasta)
  • Apheresis
  • Houston, Texas
    MD Anderson Cancer Center
Jul 31, 2012

Non-Hodgkin's Lymphoma Trial in Houston (Rituximab)

Terminated
  • Non-Hodgkin's Lymphoma
  • Houston, Texas
    UT MD Anderson Cancer Center
Jul 27, 2012